KT-362 free base

CAS No. 93392-97-3

KT-362 free base( —— )

Catalog No. M36550 CAS No. 93392-97-3

KT-362 is a calcium channel blocker with antihypertensive properties that can be used in the study of cardiovascular disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 174 In Stock
10MG 258 In Stock
25MG 392 In Stock
50MG 551 In Stock
100MG 762 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KT-362 free base
  • Note
    Research use only, not for human use.
  • Brief Description
    KT-362 is a calcium channel blocker with antihypertensive properties that can be used in the study of cardiovascular disease.
  • Description
    KT-362 is a calcium channel blocker with antihypertensive properties that can be used in the study of cardiovascular disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    93392-97-3
  • Formula Weight
    400.53
  • Molecular Formula
    C22H28N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCNCCC1=CC(OC)=C(OC)C=C1)(=O)N2C=3C(=CC=CC3)SCCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mibefradil dihydroch...

    Mibefradil dihydrochloride is an blocker of calcium channel with moderate selectivity for T-type Ca2+ channels (T-type and L-type currents with IC50s of 2.7 μM and 18.6 μM, respectively). Mibefradil dihydrochloride inhibits reversibly the T- and L-type currents with IC50 values of 2.7 and 18.6 μM, respectively.

  • 2,3-Dihydroxy-4-meth...

    2,3-Dihydroxy-4-methoxyacetophenone is a natural product,it improves cognitive function and may be helpful for the treatment of Alzheimer's disease.

  • O-1602

    O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.